JP2008540536A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540536A5
JP2008540536A5 JP2008511225A JP2008511225A JP2008540536A5 JP 2008540536 A5 JP2008540536 A5 JP 2008540536A5 JP 2008511225 A JP2008511225 A JP 2008511225A JP 2008511225 A JP2008511225 A JP 2008511225A JP 2008540536 A5 JP2008540536 A5 JP 2008540536A5
Authority
JP
Japan
Prior art keywords
cells
patient
left ventricular
ventricular assist
terminated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008511225A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540536A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/017683 external-priority patent/WO2006122005A2/en
Publication of JP2008540536A publication Critical patent/JP2008540536A/ja
Publication of JP2008540536A5 publication Critical patent/JP2008540536A5/ja
Pending legal-status Critical Current

Links

JP2008511225A 2005-05-09 2006-05-09 心疾患の患者における補助治療としての細胞性心筋形成術 Pending JP2008540536A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67897605P 2005-05-09 2005-05-09
PCT/US2006/017683 WO2006122005A2 (en) 2005-05-09 2006-05-09 Cellular cardiomyoplasty as supportive therapy in patients with heart disease

Publications (2)

Publication Number Publication Date
JP2008540536A JP2008540536A (ja) 2008-11-20
JP2008540536A5 true JP2008540536A5 (enExample) 2009-06-18

Family

ID=37397196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511225A Pending JP2008540536A (ja) 2005-05-09 2006-05-09 心疾患の患者における補助治療としての細胞性心筋形成術

Country Status (5)

Country Link
US (1) US8889122B2 (enExample)
EP (1) EP1885185A4 (enExample)
JP (1) JP2008540536A (enExample)
AU (1) AU2006244197A1 (enExample)
WO (1) WO2006122005A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9462960B2 (en) * 2003-02-21 2016-10-11 3Dt Holdings, Llc Impedance devices and methods of using the same to obtain luminal organ measurements
US8038595B2 (en) * 2006-01-25 2011-10-18 Beth Israel Deaconess Medical Center Devices and methods for tissue transplant and regeneration
RU2325843C1 (ru) * 2006-11-28 2008-06-10 Государственное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ определения критерия для проведения медикаментозной терапии и контроля за эффективностью лечения у больных безболевой ишемией миокарда
EP2607898B1 (en) * 2010-08-17 2016-01-20 Terumo Kabushiki Kaisha Method for evaluating graft
WO2014134532A1 (en) * 2013-02-28 2014-09-04 Ventrix, Inc. Methods and compositions for tissue therapy and analysis
EP3869195B1 (en) 2015-03-23 2024-03-20 Astellas Institute for Regenerative Medicine Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors
PT3970730T (pt) * 2016-02-12 2024-07-30 Mallinckrodt Pharmaceuticals Ireland Ltd Sistema para utilização e monitorização de óxido nítrico inalado com dispositivos de ajuda ventricular esquerda
CA3119068A1 (en) * 2018-11-08 2020-05-14 University Of Miami Method of determining responsiveness to cell therapy in dilated cardiomyopathy

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130141A (en) * 1988-05-24 1992-07-14 Law Peter K Compositions for and methods of treating muscle degeneration and weakness
US5143842A (en) * 1988-11-01 1992-09-01 The University Of Colorado Foundation, Inc. Media for normal human muscle satellite cells
WO1990015863A1 (en) 1989-06-13 1990-12-27 The Board Of Directors Of The Leland Stanford Junior University Isolation growth and differentiation of human muscle cells
US5538722A (en) * 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
WO1991011522A1 (en) * 1990-01-26 1991-08-08 Baylor College Of Medicine MUTATED PROMOTER REGION FROM CHICKEN SKELETAL α-ACTIN GENE
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
US5543318A (en) * 1991-06-12 1996-08-06 Smith; David A. Method of isolation, culture and proliferation of human atrial myocytes
EP0590066A4 (en) * 1991-06-12 1994-12-07 David A Smith METHOD FOR INDUCING HUMAN MYOCARDIAL CELL PROLIFERATION.
US5405772A (en) * 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
WO1995012979A1 (en) 1993-11-08 1995-05-18 The University Of Southern California Compositions and methods for transduction of cells
US6015671A (en) * 1995-06-07 2000-01-18 Indiana University Foundation Myocardial grafts and cellular compositions
US5602301A (en) * 1993-11-16 1997-02-11 Indiana University Foundation Non-human mammal having a graft and methods of delivering protein to myocardial tissue
US6239172B1 (en) * 1997-04-10 2001-05-29 Nitrosystems, Inc. Formulations for treating disease and methods of using same
US5968983A (en) * 1994-10-05 1999-10-19 Nitrosystems, Inc Method and formulation for treating vascular disease
EP1407788A2 (en) 1994-12-13 2004-04-14 Peter K. Law Myoblast therapy for mammalian diseases
WO1996038543A1 (en) 1995-04-20 1996-12-05 Diacrin, Incorporated Modified cells and methods for inhibiting xenograft rejection
US5919449A (en) * 1995-05-30 1999-07-06 Diacrin, Inc. Porcine cardiomyocytes and their use in treatment of insufficient cardiac function
US6096532A (en) * 1995-06-07 2000-08-01 Aastrom Biosciences, Inc. Processor apparatus for use in a system for maintaining and growing biological cells
US6228635B1 (en) * 1995-06-07 2001-05-08 Aastrom Bioscience, Inc. Portable cell growth cassette for use in maintaining and growing biological cells
US5985653A (en) * 1995-06-07 1999-11-16 Aastrom Biosciences, Inc. Incubator apparatus for use in a system for maintaining and growing biological cells
US6238908B1 (en) * 1995-06-07 2001-05-29 Aastrom Biosciences, Inc. Apparatus and method for maintaining and growth biological cells
EP0946713B1 (en) 1996-10-18 2007-03-07 Universite Laval Method for in vitro preconditioning of myoblasts before transplantation
CA2275436A1 (en) 1996-12-20 1998-07-02 Curis, Inc. Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells
US6099832A (en) 1997-05-28 2000-08-08 Genzyme Corporation Transplants for myocardial scars
US6110459A (en) * 1997-05-28 2000-08-29 Mickle; Donald A. G. Transplants for myocardial scars and methods and cellular preparations
CA2225185A1 (en) 1997-08-11 1999-02-11 Peter K. Law Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
US5972013A (en) * 1997-09-19 1999-10-26 Comedicus Incorporated Direct pericardial access device with deflecting mechanism and method
US6151525A (en) * 1997-11-07 2000-11-21 Medtronic, Inc. Method and system for myocardial identifier repair
US6107034A (en) * 1998-03-09 2000-08-22 The Board Of Trustees Of The Leland Stanford Junior University GATA-3 expression in human breast carcinoma
AU783935B2 (en) 1999-06-18 2006-01-05 Indiana University Research And Technology Corporation Cardiomyocytes with enhanced proliferative potential, and methods for preparing and using same
AU770889B2 (en) * 1999-07-23 2004-03-04 Genvec, Inc. Muscle cells and their use in cardiac repair
US20030113301A1 (en) 1999-07-23 2003-06-19 Albert Edge Muscle cells and their use in cardiac repair
EP1221956A2 (en) 1999-09-30 2002-07-17 McGILL UNIVERSITY Autologous marrow stem cell (msc) transplantation for myocardial regeneration
EP1412479A4 (en) * 2001-07-12 2004-07-28 Geron Corp CELLS WITH CARDIOMYOCYTE GENERATION PRODUCED FROM HUMAN PLURIPOTENT STEM CELLS
US20050244384A1 (en) * 2002-04-01 2005-11-03 Law Peter K Cellular transplantation for heart regeneration
US20040191225A1 (en) * 2002-08-06 2004-09-30 Dinsmore Jonathan H. Injection system
CA2495112A1 (en) 2002-08-09 2004-02-19 Peter K. Law Mechanisms of myoblast transfer in treating heart failure

Similar Documents

Publication Publication Date Title
Pagani et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: histological analysis of cell survival and differentiation
Menasché et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction
Gnecchi Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement
Wang et al. Cardiac microvascular functions improved by MSC-derived exosomes attenuate cardiac fibrosis after ischemia–reperfusion via PDGFR-β modulation
WO2006121532A3 (en) Treatment for heart disease
Reffelmann et al. Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium
JP2013056183A5 (enExample)
Zhang et al. Systemic milieu and age-related deterioration
US20200085875A1 (en) Platelet vesicle-engineered cells for targeted tissue repair
Mayfield et al. Resident cardiac stem cells and their role in stem cell therapies for myocardial repair
Weil et al. Stem cell stimulation of endogenous myocyte regeneration
Lilyanna et al. Cord lining-mesenchymal stem cells graft supplemented with an omental flap induces myocardial revascularization and ameliorates cardiac dysfunction in a rat model of chronic ischemic heart failure
CN107137700B (zh) 一种基于干细胞源外泌体的组合物及其在制备治疗心肌梗死的药物中的应用
Selem et al. Stem cell therapy for pediatric dilated cardiomyopathy
Fidelis-de-Oliveira et al. Soluble factors from multipotent mesenchymal stromal cells have antinecrotic effect on cardiomyocytes in vitro and improve cardiac function in infarcted rat hearts
Yokokawa et al. Transplantation of mesenchymal stem cells improves atrioventricular conduction in a rat model of complete atrioventricular block
Zhong et al. The current status and future of cardiac stem/progenitor cell therapy for congenital heart defects from diabetic pregnancy
Yue et al. Cardiac support device (ASD) delivers bone marrow stem cells repetitively to epicardium has promising curative effects in advanced heart failure
Siskin et al. A case of cardiogenic shock secondary to complement-mediated myopericarditis from influenza B infection
Premaratne et al. Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction
WO2007048352B1 (en) Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries
Meng et al. Weight loss after laparoscopic sleeve gastrectomy ameliorates the cardiac remodeling in obese Chinese
JP2008540536A (ja) 心疾患の患者における補助治療としての細胞性心筋形成術
CN114010658A (zh) TREM2hi巨噬细胞在制备治疗心脏功能障碍药物中的应用
Kim et al. A long road for stem cells to cure sick hearts: update on recent clinical trials